Overview of Urecrem

Urecrem is a prescription-strength topical cream primarily used to treat various dry, rough, and thickened skin conditions. It is manufactured by a specialty pharmaceutical company and is available by prescription only (Rx status), which distinguishes its potency from standard over-the-counter moisturizers.

Urecrem is classified as a highly effective keratolytic emollient, a property widely supported by decades of pharmacological studies published in dermatological literature.

Quick Facts

Property	Description
Active ingredient	Urea (typically 40% concentration)
Form	Topical cream (emollient base)
Pharmacological class	Keratolytic Emollient, Humectant
Common use	Treating dry, scaly, and thickened skin (hyperkeratosis)
Rx/OTC Status	Prescription Only (Rx)

The main active ingredient in Urecrem is urea, typically found in a high concentration of around 40%. The specific cream base (emollient form) is designed to enhance the penetration of urea into the thickest skin layers while helping to minimize potential irritation.

As a medicine, urea acts as a humectant (drawing water into the skin) and a keratolytic agent. Its efficacy is clinically recognized for its ability to chemically disrupt the bonds in the skin's keratin structure, allowing the hardened, scaly tissue to dissolve and be shed naturally.

A typical use scenario is for patients managing chronic conditions like severe psoriasis plaques or ichthyosis (genetic dry skin), where Urecrem is applied to restore the skin’s texture and hydration balance when milder, non-prescription products are found to be inadequate.

What side effects are possible with Urecrem?

Possible side effects and safety information

The safety profile of high-concentration urea cream (Urecrem) is defined by officially documented adverse reactions, which are primarily localized and confined to the area of application. These effects are classified under Skin and Subcutaneous Tissue Disorders.

According to government regulatory documents, the most commonly documented adverse effects include transient stinging, transient burning, itching (pruritus), irritation, redness, and rash. These local effects are described as temporary and typically disappear upon discontinuing the use of the product. No quantitative frequency classifications (such as common or rare) are formally applied to these reactions in the regulatory information.

Serious Adverse Reactions and Safety Constraints

While the primary effects are local, the most serious documented safety concern is the risk of a hypersensitivity reaction (allergy) to the active ingredient or any excipient in the formulation. A known or suspected hypersensitivity constitutes a restriction on use.

Safety constraints require that the cream is restricted to external use only and that contact must be avoided with the eyes, lips, and mucous membranes.

Special Population Considerations

Official safety statements address the use of this formulation in certain populations. For pregnancy and lactation, caution is advised, and use should only be considered when clearly necessary, reflecting standard regulatory guidance when comprehensive data may be limited. The profile does not specify unique adverse reaction patterns for older adults or individuals with hepatic or renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

This information describes the formally documented manifestations of overdose with high-concentration urea cream (Urecrem) and the emergency actions mandated by regulatory authorities. The content is strictly based on official prescribing information, focusing only on documented signs and required responses.

Documented Overdose Manifestations

Overdose with this topical agent is primarily considered in the context of accidental ingestion, which may lead to systemic toxicity. The official labeling documents potential manifestations including nausea, vomiting, headache, dizziness, and lethargy. Excessive topical use, particularly on compromised skin, may be indicated by increased local irritation or a burning sensation.

In cases of severe systemic exposure, a critical concern is the development of electrolyte disturbances, such as hypernatremia (elevated sodium levels), which are metabolic consequences of the excessive urea load.

Officially Required Emergency Actions

The regulatory guidance is explicit regarding severe exposure:

Seek immediate medical attention or contact a poison control center in the event of accidental ingestion or if systemic symptoms are observed.
Management is defined as symptomatic and supportive treatment.
No specific antidote is known for urea toxicity.
Hospital monitoring may be required for severe systemic exposure to observe and manage potential fluid and electrolyte imbalances.

Therapeutic Uses of Urecrem

What Urecrem Treats: Main Uses and Benefits

The prescription-strength formulation of Urecrem is applied in addressing conditions presenting with systemic or localized discomfort related to tissue hardening, and may be relevant when supportive symptom management is appropriate.

This high-concentration cream is commonly used across conditions presenting with significant symptomatic burden related to hyperkeratosis. The cream is relevant in conditions characterized by periods of heightened symptoms related to hyperkeratosis, including severe, chronic psoriasis, ichthyosis, and xerosis, as well as managing localized issues such as calluses, corns, and dystrophic nails. The primary therapeutic benefit is to contribute to easing the symptom load related to the presence of excess, hardened, and scaly tissue.

This support helps to ease the overall symptom load and contributes to improved comfort during symptomatic periods, particularly in chronic conditions. It is applied when additional management of discomfort is required, particularly when symptoms related to tissue thickening interfere with daily comfort. “It is commonly used to help with symptoms related to hardened skin that create noticeable functional strain.”

Quick Fact: Relief for Hardened, Scaly Skin

Urecrem is relevant for easing symptoms related to pronounced skin rigidity in specific localized areas, and is considered relevant for managing the rough, bumpy texture associated with various severe hyperkeratotic disorders.

Regulatory References

DailyMed (NIH/FDA) product label for Urea Cream

Eligibility and Restrictions for Use

The regulatory eligibility for Urecrem is defined by patient sensitivity and the condition of the application site. Urecrem is contraindicated for any individual with a known or suspected hypersensitivity to the active ingredient, urea, or any other component in the cream. Furthermore, the cream must not be applied to areas of broken, inflamed, or infected skin, nor should contact with the eyes, lips, or mucous membranes be permitted.

For age-related eligibility, the product is generally permitted for use in adults and older adults. However, safety and effectiveness have not been established in pediatric patients according to regulatory labeling, and use may be restricted in children under two years of age.

Use during pregnancy is conditional and advised only if clearly needed, as insufficient data exists on the effects of topical urea on the fetus. Caution is also required for nursing mothers, since it is not known whether the drug is excreted in human milk. Finally, use should not be extensive in patients with severe renal impairment due to the risk of systemic absorption.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Urecrem, which contains urea as the active ingredient, is a topical dermatological product. Due to its mechanism of action and primary use on the surface of the skin, the risk for systemic drug-drug interactions is generally considered to be low. For most commonly prescribed systemic medications, no clinically significant interactions with topical urea are reported.

However, urea, particularly in higher concentrations, possesses keratolytic properties and can temporarily affect the structure of the outermost layer of the skin. This effect may enhance the absorption of other substances applied to the same area. This is a crucial consideration when Urecrem is used concurrently with other topical medicinal products.

Product Category	Interaction Note
Other Topical Products	Use caution; urea may increase the skin penetration and potential systemic exposure of other topically applied drugs (e.g., corticosteroids, antifungals). Consultation with a healthcare provider is necessary before co-applying other topical medicines to the same area.
Systemic Medicines	No specific systemic drug-drug interactions are widely documented or expected, given the minimal absorption of topical urea.

To ensure proper use, patients should provide their healthcare provider or pharmacist with a complete list of all topical and systemic prescription, over-the-counter, and supplement products they are using. The application site should be clear of other products unless specifically advised otherwise, and the product should not be used on open wounds or severely irritated skin where absorption may be heightened.

Mechanism of Action

How Urecrem Works: Mechanism of Action

Urecrem operates via a two-part peripheral mechanism confined to the stratum corneum (the outermost skin layer), where it influences epidermal structure and water content dynamics.

Keratolytic Action: Breaking Down Protein Structure

The molecule acts as a keratolytic agent, targeting the rigid structure of the stratum corneum. It denatures keratin and disrupts the hydrogen bonds that anchor corneocytes, leading to the dissolution of the intercellular matrix. This cascade results in the physical reorganization and detachment (exfoliation) of corneocyte layers in areas of protein aggregation.

Humectant and Modulatory Effects

Urea is highly hygroscopic, binding water and facilitating its uptake into the stratum corneum. This mechanism increases the tissue’s water-holding capacity and influences its mechanical properties, such as flexibility and elasticity. Furthermore, Urecrem can influence keratinocyte differentiation by regulating the gene expression of crucial barrier proteins (like filaggrin) and antimicrobial peptides, contributing to the reinforcement of the skin barrier structure.

Dosage and Administration Information

How to Use Urecrem (Urea 40% Cream)

The usage of Urecrem is defined by a standardized topical regimen, which specifies the application method and frequency as outlined in regulatory documentation. The medicine is provided as a high-concentration cream designed for external use only.

Official Administration Protocol

The standard protocol mandates that the cream be applied directly to the skin or affected nails in a uniform manner. The administration is typically scheduled twice per day (B.I.D.), with a goal of ensuring consistent coverage of the hyperkeratotic lesion.

Administration Parameter	Official Instruction
Route & Form	Topical Cream (External Use Only)
Dosing Frequency	Twice per day (B.I.D.)
Application Amount	A thin layer sufficient to cover the affected area(s)
Specific Action	Rub cream in until completely absorbed

Administration Constraints

Urecrem must be applied strictly as directed by a healthcare professional. Application is restricted to the specific lesions being addressed, and contact must be avoided with eyes, lips, and all mucous membranes to maintain proper use. The official administration rules establish the boundaries for application, defining Urecrem as a site-specific, high-strength topical therapy. While duration is determined by the treating physician for conditions ranging from localized to chronic, the established twice-daily frequency is central to the standardized usage protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Urecrem

Evidence for Hyperkeratotic Plaque Psoriasis

Research has explored the use of high-concentration urea formulations in adults managing thick, scaly psoriasis plaques. These studies often used Randomized Controlled Trials (RCTs) and Systematic Reviews, with researchers monitoring physical changes such as scaling reduction and shifts in skin thickness. Many trials involved combination use alongside other dermatological treatments, which limits insight into the formulation's specific contribution as a monotherapy. The evidence base contains few large-scale RCTs specific to the 40% cream, and long-term effects are not fully established.

Evidence for Ichthyosis and Severe Scaling Conditions

Clinical Studies and Systematic Reviews have monitored outcomes related to skin hydration and patient-reported discomfort for conditions like ichthyosis. Research included both adults and, in some reports, children and adolescents with scaling conditions. Studies tracked changes in skin hydration levels and objective evaluations of scaling severity. However, certainty remains low in some areas because many existing studies are small-scale or involve mixed patient groups, leading to findings that were sometimes varied.

Evidence for Localized Thickening (Calluses, Corns, and Xerosis)

For severe dry skin (xerosis) and pronounced localized thickening, the evidence is supported by Meta-analyses and specialized Observational Case Series. For xerosis, research examined objective outcomes like increases in skin hydration levels. For highly localized areas, the research describes the formulation's use in specialized settings, with studies monitoring the softening of hardened tissue. The evidence for localized hyperkeratosis primarily comes from modest sample sizes and specialized clinical reports.

Understanding Evidence Gaps and Uncertainties

Research has mainly evaluated the formulation in general adult populations. Evidence available for specific groups, such as dedicated studies in children or those with specific comorbidities, remains limited. One key limitation is that comparative evidence is lacking in high-quality trials that directly compare the 40% formulation against alternative high-potency treatments. Evidence is also limited regarding long-term outcomes and the durability of observed responses.

Key Studies & References

Urea Cream 40% Prescription Drug Label (DailyMed/FDA)

Frequently Asked Questions (FAQ)

Common questions about Urecrem (FAQ)

Q: Is Urecrem available without a prescription?

According to the official product information, Urecrem (Urea 40% cream) is generally categorized by regulatory authorities as a Human Prescription Drug (Rx Only). This status indicates that the product is dispensed by prescription only.

Q: What are the official approved uses of Urecrem?

The official indications include the management of hyperkeratotic surface lesions to promote normal healing. This covers treatment for various thickened skin conditions, such as dry, rough skin, psoriasis, eczema, ichthyosis, xerosis, corns and calluses, and certain damaged nails.

Q: Is Urecrem safe to use while pregnant or breastfeeding?

The official regulatory profile suggests caution for use during both pregnancy and lactation. Use is indicated only if clearly needed, as it is not currently known whether the drug can cause fetal harm or if it is excreted in human milk.

Q: Are there different strengths or versions of Urecrem?

The specific prescription product known as Urecrem (or Urea 40% Cream) contains urea at a 40% concentration. This is the defined strength classified as a Human Prescription Drug under the FDA/DailyMed system.

Q: Can Urecrem be used by older adults?

Official information indicates the product is generally permitted for use in adults, including older adults. The regulatory safety profile does not specify unique adverse reaction patterns for this population.

Q: Are there any long-term side effects listed for Urecrem?

Officially documented adverse effects are primarily local and transient, such as stinging or irritation. Studies related to long-term use and certain risks, such as carcinogenic potential, have not been performed to date, according to regulatory documents.

Q: Are the side effects of Urecrem reversible?

Documented local adverse effects, such as transient stinging, burning, itching, or irritation, are described as temporary. These effects typically disappear after the product is discontinued.

Q: Is it normal to feel a slight tingling sensation after applying Urecrem?

Regulatory documents list transient stinging and burning as documented adverse reactions. These effects are described as temporary and are expected to subside with continued use.

Q: Does Urecrem cause dryness or flaking of the skin?

The official safety documents list transient irritation, redness, and rash among the documented local adverse effects. Dryness or flaking is not specifically listed, but irritation is a known local reaction.

Q: Can Urecrem cause weight gain or changes in appetite?

Systemic adverse effects such as weight gain or changes in appetite are not listed among the officially documented adverse reactions for this topical formulation. This is consistent with its minimal systemic absorption.

Q: Can Urecrem be used on sensitive areas of the body?

The warnings specify that use is restricted from contact with the eyes, lips, and mucous membranes. Furthermore, the product should not be applied to any broken, inflamed, or infected skin.

Q: Does Urecrem make your skin more sensitive to the sun?

Photosensitivity (an increased sensitivity to the sun) is not listed as a documented adverse reaction or warning in the product’s regulatory labeling.

Q: What should I do if the side effects of Urecrem are bothering me?

Official precautions indicate that if local effects like redness or irritation occur, or if the skin condition worsens or a rash develops, discontinuation of the product is advised, and consultation with a healthcare professional is documented as required.

Q: I forgot a use of Urecrem; what happens?

Regulatory documents indicate that if a scheduled use is missed, the dose may be applied as soon as it is remembered. However, if it is close to the next scheduled use, the missed dose should be skipped, and the regular schedule resumed. Extra product should not be used to compensate for a missed dose.

Q: Can Urecrem interact with common pain relievers?

Due to the product's topical use and minimal systemic absorption, no specific drug-drug interactions with systemic medicines, including common pain relievers, are widely documented in regulatory information.

Q: Does Urecrem have a known interaction with caffeine?

No specific interactions between the topical product and common food components or substances like caffeine are listed in the official regulatory documents, given the low risk of systemic absorption.

Q: Can Urecrem be used with certain cosmetics or moisturizers?

Urecrem’s keratolytic properties may temporarily affect the skin's barrier. This could potentially enhance the absorption of other substances, including cosmetics or non-medicinal moisturizers, if they are applied to the same area.

Q: Are there special warnings about using Urecrem in certain climates?

The official warnings and precautions provided in the regulatory labeling do not include specific instructions or restrictions related to using the product in certain environmental climates.

Q: Is Urecrem a new drug, or has it been around for a while?

The active ingredient, urea, has been used in dermatological formulations and pharmacological studies for many decades. The prescription-strength 40% cream has established regulatory status under the FDA/DailyMed system.

How should Urecrem be stored and disposed of?

Storage Conditions and Protection

Urecrem must be stored at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F), as specified in the official regulatory labeling. To maintain product integrity, the cream must be protected from freezing and excessive heat, and the container should be kept tightly closed when not in use. Like all prescription medications, Urecrem must be stored out of the reach of children.

Disposal Requirements

Unused or expired Urecrem should be discarded according to official government disposal guidelines. If a drug take-back program is unavailable, the product should be mixed with an undesirable substance, such as dirt or used coffee grounds, and placed in a sealed container before being thrown into the household trash. The medication should not be flushed down the toilet, and all personal information on the container must be scratched out prior to disposal.

Urecrem